Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Navigation icon on Pluang platform
US Stocks
Invest in the world’s largest market with US Stocks
Navigation icon on Pluang platform
Crypto
Unleash the unlimited potential of Crypto
Navigation icon on Pluang platform
ID Stocks
Invest in leading Indonesian companies with ID Stocks
Navigation icon on Pluang platform
Mutual Funds
Worry-free investments with Mutual Funds
Navigation icon on Pluang platform
Gold
The simplest way to invest in Gold
Navigation icon on Pluang platform
Options
Maximize market opportunities with Options Trading
Navigation icon on Pluang platform
Crypto Futures
Leverage your potential with Crypto Futures
Navigation icon on Pluang platform
Explore
Choose from 1000+ available assets
Features
Pluang support - get 24/7 expert trading help
Pro Tools for Pro Traders
Uncover the powerful trading features
Pro Features
Navigation icon on Pluang platform
Pluang Web Trading
Navigation icon on Pluang platform
Leverage
Navigation icon on Pluang platform
Pluang support - get 24/7 expert trading help
Built for Investors
Experience investing with simplified features
Pockets
Navigation icon on Pluang platform
Auto Invest
Navigation icon on Pluang platform
USD Yield
Navigation icon on Pluang platform
Pluang Cuan
Navigation icon on Pluang platform
24-Hour Market
Navigation icon on Pluang platform
Aura AI
Navigation icon on Pluang platform
FeesSafety
Academy
Navigation icon on Pluang platform
Latest for You
Get up-to-date financial news and investing tips & information
Navigation icon on Pluang platform
Blog
Find various tips & information to become a knowledgeable investor
Navigation icon on Pluang platform
News and Analysis
Read the latest information about finance and investment
Navigation icon on Pluang platform
Learn
Become a smarter investor by learning the basics of investing
Navigation icon on Pluang platform
Glossary
Learn investment terms to understand investing better
More
Navigation icon on Pluang platform
Promo & Referral
Discover exclusive opportunities to level up your investments
Navigation icon on Pluang platform
Impact Report
Discover how your steps with Pluang contribute to big changes and lasting impact
Navigation icon on Pluang platform
Investment Clubs (Coming Soon)
Join hands with like-minded investors to grow wealth together
Pluang support - get 24/7 expert trading help
Support
About Us
Browse Pluang investment products menu
Help Center
Browse Pluang investment products menu
Contact
Browse Pluang investment products menu
FAQ
Browse Pluang investment products menu
Career
Browse Pluang investment products menu
Tax Reporting Guide
Browse Pluang investment products menu
Pluang+
|
Home/News Feed/Pluvicto improves survival in metastatic hormone-sensitive prostate cancer across patient subgroups, Novartis reports
NVS
$150.17
-$1.23 -0.81%

Pluvicto improves survival in metastatic hormone-sensitive prostate cancer across patient subgroups, Novartis reports

Company Fundamentals
31 May 2026
Globe News Wire
View Source
Bullish
pluang ai news

Novartis announced that Pluvicto combined with standard care significantly improves radiographic progression-free survival (rPFS) in patients with PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC), regardless of disease volume or presentation. The Phase 3 PSMAddition trial showed a 28% reduction in risk of progression or death, supporting early use of Pluvicto in this patient group. Safety profiles were consistent, with manageable side effects. Novartis also presented promising Phase 1 data for its actinium-based radioligand therapy, 225 Ac-PSMA-617, advancing two Phase 3 trials for metastatic castration-resistant prostate cancer (mCRPC). Regulatory decisions for Pluvicto are expected in the second half of 2026.

More News (NVS)

Global Bioprocess Automation Software market to reach $6.19B by 2035 with 14% CAGR, driven by personalized medicine and scalable production.

Global Bioprocess Automation Software market to reach $6.19B by 2035 with 14% CAGR, driven by personalized medicine and scalable production.

The global Bioprocess Automation Software market, valued at $1.67 billion in 2025, is projected to grow to $6.19 billion by 2035 at a 14% CAGR. This growth is fueled by the increasing demand for personalized medicine, flexible manufacturing processes...

Market News
Bullish
5 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App